Tissue cathepsins as tumor markers

Clinica Chimica Acta

Volumn 237, Issue 1-2, 1995, Pages 67-78

  Schwartz, Morton K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; Cathepsins; Malignant cell; Metastatic process; Proteolytic enzymes

Indexed keywords

CATHEPSIN B; CATHEPSIN D; TUMOR MARKER;

BASEMENT MEMBRANE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURVIVAL; CATALYSIS; COLORECTAL CANCER; CONFERENCE PAPER; ENZYME ACTIVE SITE; HUMAN; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; TUMOR RECURRENCE;

CATHEPSIN B; CATHEPSIN D; CATHEPSINS; HUMAN; NEOPLASM METASTASIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029021787     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(95)06065-L     Document Type: Article

References (36)

1. Proteases cathepsins — A view
2. Cloning and sequencing of the 52-kDa cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11
3. Two site immunoenzymetric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues
4. A secreted glycoprotein induced by estrogen in human breast cancer cell lines
5. Increased secretion, altered processing and glycosylation of procathepsin D in mannary cancer cells
6. Distribution of the 52-kDa estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry
7. Immunoenzymatic assay of 52-kDa cathepsin D in 182 breast cancer cytosols Low correlation with other prognostic markers
8. A two-site immunoenzymometric assay of 52-kDa procathepsin D and its use in human breast diseases
9. Cathepsin D and prognosis in breast cancer
10. Association between high concentration of 52-kDa cathepsin D and poor prognosis in primary human breast cancer
11. Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls
12. Increased plasma cathepsin D concentrations in hepatic carcinoma and cirrhosis but not in breast cancer
13. Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival
14. Immunoradiometric assay of procathepsin D in breast cancer cytosol: Relative prognostic value versus total cathepsin D
15. Quantitative immunohistochemical determination of cathepsin D and its relation with other variables
16. levels in primary breast cancers: Relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status
17. The role of cathepsin D in the invasiveness of human breast cancer cells
18. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathologic characteristics
19. Cathepsin D and C-erb-B 2 have an additive prognostic value for breast cancer patients
20. Biochemical parameters for prognostic evaluation in patients with breast cancer
21. Diagnostic value of PS2 and cathepsin D in 710 human primary breast tumor: multivariate analysis
22. Evaluation of cathepsin D as a prognostic factor in breast cancer
23. Response to PM Ravdin (BCRT 24: 219–226, 1993) ‘Evaluation of cathepsin D as a prognostic factor in breast cancer’
24. D activity levels in colorectal cancer: correlation with other prognostic parameters of malignant progression
25. Occurence and interfationships of urokinase-type plasminogen activator inhibitor-1 and cathepsin D in human ovarian tissues
26. Estrogen receptors and cathepsin D in human thyroid tissue
27. Mechanisms of human bladder tumor invasion. Role of protease cathepsin B
28. Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastases
29. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically-treated patients with lung adenocarcinoma
30. Diagnostic value of increased lung tumor tissue cathepsin B
31. Cathepsin B expression in colorectal carcinoma correlates with progression and shortened patient survival
32. Cathepsin B and other proteases in human colorectal carcinoma (comment)
33. Pancreatic trypsinogen and cathepsin B in human pancreatic carcinoma and associated metastatic lesions